Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 4 3Phase NA 2Phase 2 2Phase 1 2

Status

Completed 2Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Head and Neck Neoplasms 3Colonic Neoplasms 3Chronic Pain 3Cancer Pain 3Supratentorial Neoplasms 2Pain, Postoperative 2Pain 2Neoplastic Cells, Circulating 2Neoplasms 2Colorectal Neoplasms 2Agnosia 2Substance Withdrawal Syndrome 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Nalbuphine Allergy 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Breakthrough Pain 1Brain Neoplasms 1Age Problem 1Abdominal Cancer 1

Interventions

Oxycodone 9Fentanyl 5Morphine 3Ethanol 3Naloxone 2Buprenorphine 2Acetaminophen 2rofecoxib 1Ultracet 1Radiofrequency Ablation 1Polyethylene Glycols 1Methadone 1Magnesium Hydroxide 1Hydromorphone 1Electrolytes 1Duration of Therapy 1Dosage Forms 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Cancer Pain × Morphine × Clear all
NCT02660229 2018-11-19

SWITCH

Mundipharma Korea Ltd

Phase 4 Completed
66 enrolled 10 charts

Cancer Pain

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed
518 enrolled 11 charts

Cancer Pain, Neoplasms

NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended
320 enrolled

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡